CD109 and hepatocellular carcinoma: Reduced CD109 expression on TEC correlates with advanced tumor characteristics, such as larger size and increased microvascular invasion (116), and is also associated with enhanced tumor progression, proliferation, migration, and invasion of hepatoma cells through increased secretion of interleukin-8 (IL-8), a potent proinflammatory cytokine (116).